These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 20943039)

  • 1. Role of etanercept in the treatment of tumor necrosis factor receptor-associated periodic syndrome: personal experience and review of the literature.
    Cantarini L; Rigante D; Lucherini OM; Cimaz R; Laghi Pasini F; Baldari CT; Benucci M; Simonini G; Di Sabatino V; Brizi MG; Galeazzi M
    Int J Immunopathol Pharmacol; 2010; 23(3):701-7. PubMed ID: 20943039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumour necrosis factor receptor-associated periodic syndrome (TRAPS): state of the art and future perspectives.
    Cantarini L; Lucherini OM; Muscari I; Frediani B; Galeazzi M; Brizi MG; Simonini G; Cimaz R
    Autoimmun Rev; 2012 Nov; 12(1):38-43. PubMed ID: 22884554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TNF receptor-associated periodic syndrome (TRAPS): description of a novel TNFRSF1A mutation and response to etanercept.
    Jesus AA; Oliveira JB; Aksentijevich I; Fujihira E; Carneiro-Sampaio MM; Duarte AJ; Silva CA
    Eur J Pediatr; 2008 Dec; 167(12):1421-5. PubMed ID: 18408954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrent abdominal pain as the presentation of tumor necrosis factor receptor-associated periodic syndrome (TRAPS) in an Asian girl: a case report and review of the literature.
    Chen YJ; Yu HH; Yang YH; Lau YL; Lee WI; Chiang BL
    J Microbiol Immunol Infect; 2014 Dec; 47(6):550-4. PubMed ID: 22921805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Typical and severe tumor necrosis factor receptor-associated periodic syndrome in the absence of mutations in the TNFRSF1A gene: a case series.
    Cantarini L; Lucherini OM; Cimaz R; Rigante D; Baldari CT; Laghi Pasini F; Galeazzi M
    Rheumatol Int; 2012 Dec; 32(12):4015-8. PubMed ID: 20473499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in the diagnosis and treatment of tumor necrosis factor receptor-associated periodic syndrome.
    Aguado-Gil L; Irarrazaval-Armendáriz I; Pretel-Irazabal M
    Actas Dermosifiliogr; 2013 Sep; 104(7):617-22. PubMed ID: 23891452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Failure of sustained response to etanercept and refractoriness to anakinra in patients with T50M TNF-receptor-associated periodic syndrome.
    Quillinan N; Mannion G; Mohammad A; Coughlan R; Dickie LJ; McDermott MF; McGonagle D
    Ann Rheum Dis; 2011 Sep; 70(9):1692-3. PubMed ID: 21378401
    [No Abstract]   [Full Text] [Related]  

  • 8. The TNF receptor-associated periodic syndrome (TRAPS): emerging concepts of an autoinflammatory disorder.
    Hull KM; Drewe E; Aksentijevich I; Singh HK; Wong K; McDermott EM; Dean J; Powell RJ; Kastner DL
    Medicine (Baltimore); 2002 Sep; 81(5):349-68. PubMed ID: 12352631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and functional characterisation of a novel TNFRSF1A c.605T>A/V173D cleavage site mutation associated with tumour necrosis factor receptor-associated periodic fever syndrome (TRAPS), cardiovascular complications and excellent response to etanercept treatment.
    Stojanov S; Dejaco C; Lohse P; Huss K; Duftner C; Belohradsky BH; Herold M; Schirmer M
    Ann Rheum Dis; 2008 Sep; 67(9):1292-8. PubMed ID: 18180277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumour necrosis factor receptor-associated periodic syndrome caused by a rare mutation in the TNFRSF1A gene, and with excellent response to etanercept treatment.
    Cantarini L; Lucherini OM; Galeazzi M; Fanti F; Simonini G; Baldari CT; Laghi Pasini F; De Martino M; Cimaz R
    Clin Exp Rheumatol; 2009; 27(5):890-1. PubMed ID: 19917181
    [No Abstract]   [Full Text] [Related]  

  • 11. Systemic cytokine levels and the effects of etanercept in TNF receptor-associated periodic syndrome (TRAPS) involving a C33Y mutation in TNFRSF1A.
    Nowlan ML; Drewe E; Bulsara H; Esposito N; Robins RA; Tighe PJ; Powell RJ; Todd I
    Rheumatology (Oxford); 2006 Jan; 45(1):31-7. PubMed ID: 16287931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor necrosis factor receptor-associated periodic fever syndrome in a 58-year-old man: caution not to discount TRAPS as a diagnosis in older patients.
    Sinožić D; Toplak N; Milotić I
    J Clin Rheumatol; 2011 Sep; 17(6):325-8. PubMed ID: 21869706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor necrosis factor receptor 1-associated periodic syndrome without fever: cytokine profile before and during etanercept treatment.
    Morbach H; Richl P; Stojanov S; Lohse P; Girschick HJ
    Rheumatol Int; 2009 Dec; 30(2):207-12. PubMed ID: 19381634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Progress in classification and treatment for TNF receptor-associated periodic syndrome].
    Tsukamoto H; Ueda N; Horiuchi T
    Nihon Rinsho Meneki Gakkai Kaishi; 2011; 34(5):361-8. PubMed ID: 22041423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful treatment of a patient with tumor necrosis factor receptor-associated periodic syndrome using a half-dose of etanercept.
    Kusuhara K; Hoshina T; Saito M; Ishimura M; Inoue H; Horiuchi T; Sato T; Hara T
    Pediatr Int; 2012 Aug; 54(4):552-5. PubMed ID: 22830546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modified regimen of etanercept for tumor necrosis factor receptor associated periodic syndrome (TRAPS) like illness.
    Dhanrajani A; Khubchandani RP
    Indian Pediatr; 2014 Jan; 51(1):55-7. PubMed ID: 24561467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor necrosis factor receptor-associated periodic syndrome as a cause of recurrent abdominal pain in identical twins and description of a novel mutation of the TNFRSF1A gene.
    Lee RU; Saland S; Sullivan S
    J Pediatr Gastroenterol Nutr; 2013 Apr; 56(4):e22-3. PubMed ID: 22343913
    [No Abstract]   [Full Text] [Related]  

  • 18. [Tumor necrosis receptor associated periodic syndrome (TRAPS): State of the art].
    Georgin-Lavialle S; Kone-Paut I; Delaleu J; Sarrabay G; Grateau G; Touitou I; Hentgen V
    Rev Med Interne; 2018 Apr; 39(4):256-264. PubMed ID: 29525418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lessons from anti-TNF biologics: infliximab failure in a TRAPS family with the T50M mutation in TNFRSF1A.
    Nedjai B; Quillinan N; Coughlan RJ; Church L; McDermott MF; Hitman GA; Turner MD
    Adv Exp Med Biol; 2011; 691():409-19. PubMed ID: 21153346
    [No Abstract]   [Full Text] [Related]  

  • 20. Prospective study of anti-tumour necrosis factor receptor superfamily 1B fusion protein, and case study of anti-tumour necrosis factor receptor superfamily 1A fusion protein, in tumour necrosis factor receptor associated periodic syndrome (TRAPS): clinical and laboratory findings in a series of seven patients.
    Drewe E; McDermott EM; Powell PT; Isaacs JD; Powell RJ
    Rheumatology (Oxford); 2003 Feb; 42(2):235-9. PubMed ID: 12595616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.